Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group.
Galantamine in AD: randomized, placebo-controlled trial with 6-month extension; the Galantamine USA-1 Study Group.